Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDI Buys Group DCA, An E-Promotion Company

This article was originally published in The Pink Sheet Daily

Executive Summary

PDI, one of the pharma industry's major contract sales organizations, is acquiring an interactive, digital communications company, as part of a broader overhaul of its business.

You may also be interested in...



InVentiv Sees More Opportunities To Serve Pharma As Private Vs. Public Company

Private equity firm Thomas H. Lee Partners agrees to acquire contract sales and services company inVentiv Health for $1.1 billion.

As Pharma Downsizes Its Sales Reps, A CSO Becomes More Flexible

As pharmaceutical companies reorganize their commercial operations, contract sales organizations are accelerating efforts to carve out new roles to meet industry needs

Making The Most Of ACOs: How Biopharma Is Adapting To New Customer Segment

ACOs have been one of the most hyped innovations in the US health care sector this decade. The buzz may be overdone, but ACOs are now established as a different—and confusing—new customer segment for pharma. How is industry adjusting?

Topics

UsernamePublicRestriction

Register

PS122308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel